Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 05/31/2021 (updated monthly) $1,346.4 (M)
Net Assets - Class C As of 05/31/2021 (updated monthly) $60.0 (M)

Positions As of 05/31/2021

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 05/31/2021 (updated monthly) $29,755.26(M) $42,611.21(M)
P/B RatioAs of 05/31/2021 (updated monthly) 4.80 5.77
P/E Ratio (12-mo Forward)As of 05/31/2021 (updated monthly) 14.28 13.19
Price to Cash FlowAs of 05/31/2021 (updated monthly) 15.39 15.29

Portfolio Details

Asset AllocationAs of 05/31/2021

[name] [value]
Equity 99.30%
Cash & Cash Equivalents 0.70%

Geographic BreakdownAs of 05/31/2021

[name] [value]
United States 92.64%
Denmark 2.22%
Canada 1.83%
Netherlands 1.18%
Switzerland 1.15%
Cash & Cash Equivalents 0.70%
United Kingdom 0.28%

sector breakdownAs of 05/31/2021

[name] [value]
Biotechnology 77.99%
Pharmaceuticals 12.73%
Life Sciences Tools & Services 5.64%
Diversified Capital Markets 1.69%
Other Diversified Financial Services 0.74%
Cash & Cash Equivalents 0.70%
Health Care Equipment 0.36%
Health Care Facilities 0.15%

TOP TEN HOLDINGSAs of 05/31/2021

Issuer Country Industry % of total
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.82%
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.63%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.16%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.78%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.55%
HORIZON PHARMA PLC United States Pharmaceuticals, Biotechnology & Life Sciences 3.65%
JAZZ PHARMACEUTICALS PLC United States Pharmaceuticals, Biotechnology & Life Sciences 2.94%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.94%
MIRATI THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.86%
NOVAVAX INC United States Pharmaceuticals, Biotechnology & Life Sciences 2.65%

Market Capitalization BreakdownAs of 05/31/2021

[name] [value]
<2.0 Billion 25.80%
2.0-5.0 Billion 15.21%
5.0-10.0 Billion 13.41%
10.0-25.0 Billion 11.65%
25.0-50.0 Billion 2.96%
>50.0 Billion 29.54%
N/A 1.43%